Snowden Capital Advisors LLC Karuna Therapeutics, Inc. Transaction History

Snowden Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $3,542 - $6,992	-22 Reduced 0.98%	2,231 $706,000
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $7,574 - $10,031	-46 Reduced 2.0%	2,253 $380,000
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $2,644 - $3,603	-15 Reduced 0.65%	2,299 $498,000
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $119,868 - $151,839	743 Added 47.29%	2,314 $420,000
Q4 2022 Feb 13, 2023	BUY	$191.53 - $236.82 $129,474 - $160,090	676 Added 75.53%	1,571 $308,000
Q3 2022 Nov 09, 2022	BUY	$123.79 - $277.42 $110,792 - $248,290	895 New	895 $201,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.